Exanthema Global Market Report 2025

Description

Exanthema is a term used to describe a widespread skin rash or eruption, often resulting from a viral infection such as measles, rubella, or chickenpox (varicella). It plays a crucial role in diagnosing and identifying viral illnesses, as the rash's specific characteristics can help healthcare professionals determine the cause of the infection and decide on the most suitable treatment and management approaches.

The primary types of exanthema include bacterial, viral, and other forms. Bacterial exanthema is caused by infections from bacteria such as Streptococcus or Staphylococcus, leading to skin rashes. Treatment options involve topical medications, systemic therapies, and supportive care, with diagnostic methods including clinical examination, laboratory tests, and imaging techniques. Common conditions associated with exanthema include rubeola, rubella, erythema infectiosum, and roseola infantum. These diagnostic and treatment approaches are used by various healthcare providers, including hospitals, homecare services, and specialty centers.

The exanthema market research report is one of a series of new reports from The Business Research Company that provides exanthema market statistics, including the exanthema industry global market size, regional shares, competitors with the exanthema market share, detailed exanthema market segments, market trends, and opportunities, and any further data you may need to thrive in the exanthema industry. This exanthema market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The exanthema market size has grown steadily in recent years. It will grow from $2.18 billion in 2024 to $2.28 billion in 2025 at a compound annual growth rate (CAGR) of 4.7%. The growth during the historical period can be attributed to factors such as higher healthcare spending, increased awareness about vaccination, rising disposable incomes, greater understanding of skin disorders, and a stronger focus on early detection.

The exanthema market size is expected to see steady growth in the next few years. It will grow to $2.71 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth during the forecast period can be attributed to increased investments in research and development, a higher prevalence of viral and bacterial infections, a growing emphasis on telemedicine, expanding government initiatives, and a rising demand for oral medications. Key trends during this period include advancements in treatment approaches, innovations in diagnostic techniques, technological progress, breakthroughs in medical research and technology, and the development of assistive technologies.

The increasing prevalence of viral infections is expected to drive the growth of the exanthema market in the coming years. Viral infections are illnesses caused by viruses that invade and replicate within the body's cells, resulting in various symptoms and diseases. Factors such as global travel, urbanization, climate change, and weakened immunity in populations are contributing to the rising frequency of viral infections. As more cases present with skin rashes, there is a growing need for effective exanthema treatments. Exanthema, which serves as a visible immune response to viral infections, plays a role in expelling pathogens, signaling immune activation, and assisting in diagnosis by showing the body's fight against the virus. For example, according to the Centers for Disease Control and Prevention (CDC), between 2022 and 2024, the percentage of individuals with IgM antibodies, which indicate a recent Parvovirus B19 infection, remained below 3%, but surged to 10% by June 2024. The most significant rise occurred among children aged 5-9, where the prevalence increased from 15% to 40% during this period. As a result, the increasing prevalence of viral infections is driving the growth of the exanthema market.

Companies operating in the exanthema market are making strides in developing new therapeutics, including intramuscular (IM) administration of vaccines and antiviral treatments. This method, which involves delivering vaccines or medications directly into the muscle tissue via a syringe and needle, ensures quick absorption into the bloodstream. By leveraging the rich blood supply in the muscles, the IM administration prompts a therapeutic or immune response, improving the efficacy of the treatment. For example, in March 2023, Merck & Co. Inc. announced that the FDA had approved the IM administration route for its MMRV vaccines-M-M-R II, VARIVAX, and ProQuad. This method offers greater stability and efficacy for these live-virus vaccines compared to other administration methods, making it a key step in enhancing public health efforts to prevent severe viral infections.

In September 2024, Organon, a US-based healthcare company, acquired Dermavant Sciences Ltd. for $1.2 billion. Dermavant Sciences is a clinical-stage biopharmaceutical company that focuses on developing innovative therapeutics in immunodermatology. This acquisition strengthens Organon's position in the dermatology field and aligns with its objectives to expand its portfolio with cutting-edge therapies.

Major players in the exanthema market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi SA, Abbott Laboratories, GlaxoSmithKline plc, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Company Limited, Amgen Inc., Daiichi Sankyo Company Limited, Biological E. Limited, Zydus Lifesciences Limited, Bio Farma, Meridian Bioscience Inc., West-Ward Pharmaceutical Corp., Trinity Biotech plc, Biosynth Srl, Creative Diagnostics, Taj Pharmaceuticals Limited, TestLine Clinical Diagnostics s.r.o., The Native Antigen Co. Ltd., and QED Bioscience Inc.

North America was the largest region in the exanthema market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in exanthema report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the exanthema market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The exanthema market consists of revenues earned by entities by providing services such as antiviral treatment services, vaccination services, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The exanthema market also includes sales of topical corticosteroids, antihistamines, immunosuppressants, antiviral medications, and moisturizers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Exanthema Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exanthema market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exanthema ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The exanthema market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Types: Bacterial; Viral; Other Types
2) By Treatment: Topical Treatments; Systemic Treatments; Supportive Care
3) By Diagnosis Method: Clinical Examination; Laboratory Tests; Imaging Techniques
4) By Application: Rubeola; Rubella; Erythema Infectiosum; Roseola Infantum
5) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
Subsegments:
1) By Bacterial Exanthema: Scarlet Fever; Meningococcemia; Staphylococcal Scalded Skin Syndrome (SSSS); Lyme Disease; Tuberculosis-Associated Exanthema
2) By Viral Exanthema: Measles (Rubeola); Rubella (German Measles); Varicella (Chickenpox); Roseola (Exanthem Subitum); Hand, Foot, and Mouth Disease; Parvovirus B19 (Erythema Infectiosum / Fifth Disease); Dengue Fever Rash; Zika Virus Rash
3) By Other Types of Exanthema: Drug-Induced Exanthema (Hypersensitivity Reactions); Autoimmune-Related Exanthema (Lupus, Kawasaki Disease); Allergic Dermatitis-Related Exanthema; Fungal Infections Leading to Exanthema; Environmental and Toxin-Induced Exanthema
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Sanofi SA; Abbott Laboratories; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34526

1. Executive Summary

2. Exanthema Market Characteristics

3. Exanthema Market Trends And Strategies

4. Exanthema Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Exanthema Growth Analysis And Strategic Analysis Framework

5.1. Global Exanthema PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Exanthema Market Growth Rate Analysis
5.4. Global Exanthema Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Exanthema Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Exanthema Total Addressable Market (TAM)

6. Exanthema Market Segmentation

6.1. Global Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bacterial
Viral
Other Types
6.2. Global Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical Treatments
Systemic Treatments
Supportive Care
6.3. Global Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Examination
Laboratory Tests
Imaging Techniques
6.4. Global Exanthema Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Rubeola
Rubella
Erythema Infectiosum
Roseola Infantum
6.5. Global Exanthema Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Speciality Centres
Other End-Users
6.6. Global Exanthema Market, Sub-Segmentation Of Bacterial Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Scarlet Fever
Meningococcemia
Staphylococcal Scalded Skin Syndrome (SSSS)
Lyme Disease
Tuberculosis-Associated Exanthema
6.7. Global Exanthema Market, Sub-Segmentation Of Viral Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Measles (Rubeola)
Rubella (German Measles)
Varicella (Chickenpox)
Roseola (Exanthem Subitum)
Hand, Foot, and Mouth Disease
Parvovirus B19 (Erythema Infectiosum / Fifth Disease)
Dengue Fever Rash
Zika Virus Rash
6.8. Global Exanthema Market, Sub-Segmentation Of Other Types of Exanthema, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug-Induced Exanthema (Hypersensitivity Reactions)
Autoimmune-Related Exanthema (Lupus, Kawasaki Disease)
Allergic Dermatitis-Related Exanthema
Fungal Infections Leading to Exanthema
Environmental and Toxin-Induced Exanthema

7. Exanthema Market Regional And Country Analysis

7.1. Global Exanthema Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Exanthema Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Exanthema Market

8.1. Asia-Pacific Exanthema Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Exanthema Market

9.1. China Exanthema Market Overview
9.2. China Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Exanthema Market

10.1. India Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Exanthema Market

11.1. Japan Exanthema Market Overview
11.2. Japan Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Exanthema Market

12.1. Australia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Exanthema Market

13.1. Indonesia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Exanthema Market

14.1. South Korea Exanthema Market Overview
14.2. South Korea Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Exanthema Market

15.1. Western Europe Exanthema Market Overview
15.2. Western Europe Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Exanthema Market

16.1. UK Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Exanthema Market

17.1. Germany Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Exanthema Market

18.1. France Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Exanthema Market

19.1. Italy Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Exanthema Market

20.1. Spain Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Exanthema Market

21.1. Eastern Europe Exanthema Market Overview
21.2. Eastern Europe Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Exanthema Market

22.1. Russia Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Exanthema Market

23.1. North America Exanthema Market Overview
23.2. North America Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Exanthema Market

24.1. USA Exanthema Market Overview
24.2. USA Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Exanthema Market

25.1. Canada Exanthema Market Overview
25.2. Canada Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Exanthema Market

26.1. South America Exanthema Market Overview
26.2. South America Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Exanthema Market

27.1. Brazil Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Exanthema Market

28.1. Middle East Exanthema Market Overview
28.2. Middle East Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Exanthema Market

29.1. Africa Exanthema Market Overview
29.2. Africa Exanthema Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Exanthema Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Exanthema Market, Segmentation By Diagnosis Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Exanthema Market Competitive Landscape And Company Profiles

30.1. Exanthema Market Competitive Landscape
30.2. Exanthema Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Exanthema Market Other Major And Innovative Companies

31.1. Serum Institute of India Pvt. Ltd.
31.2. Takeda Pharmaceutical Company Limited
31.3. Amgen Inc.
31.4. Daiichi Sankyo Company Limited
31.5. Biological E. Limited
31.6. Zydus Lifesciences Limited
31.7. Bio Farma
31.8. Meridian Bioscience Inc.
31.9. West-Ward Pharmaceutical Corp.
31.10. Trinity Biotech plc
31.11. Biosynth Srl
31.12. Creative Diagnostics
31.13. Taj Pharmaceuticals Limited
31.14. TestLine Clinical Diagnostics s.r.o.
31.15. The Native Antigen Co. Ltd.

32. Global Exanthema Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Exanthema Market

34. Recent Developments In The Exanthema Market

35. Exanthema Market High Potential Countries, Segments and Strategies

35.1 Exanthema Market In 2029 - Countries Offering Most New Opportunities
35.2 Exanthema Market In 2029 - Segments Offering Most New Opportunities
35.3 Exanthema Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer